Abrogation of RhoA expression and activity is associated with its aberrant splicing in diffuse-type gastric cancer cells

被引：0
|
作者：
Miyamoto, Shingo [1 ]
Nakabo, Ayaka [1 ,2 ]
Fukami, Kiyoko [2 ]
Yanagihara, Kazuyoshi [3 ]
Sakai, Ryuichi [4 ]
Yamaguchi, Hideki [1 ]
机构：
[1] Sasaki Fdn, Sasaki Inst, Dept Canc Cell Res, Tokyo, Japan
[2] Tokyo Univ Pharm & Life Sci, Lab Genome, Hachioji, Tokyo, Japan
[3] Natl Canc Ctr, EPOC, Div Biomarker Discovery, Tokyo, Japan
[4] Kitasato Univ Med, Dept Biochem, Tokyo, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2070
引用
收藏
页码：894 / 894
页数：1
相关论文
共 50 条
  • [21] Gene expression signatures for identifying diffuse-type gastric cancer associated with epithelial-mesenchymal transition
    Tanabe, Shihori
    Aoyagi, Kazuhiko
    Yokozaki, Hiroshi
    Sasaki, Hiroki
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 44 (06) : 1955 - 1970
  • [22] Soluble podoplanin as a biomarker in diffuse-type gastric cancer
    Takiguchi, Koichi
    Shoda, Katsutoshi
    Nakayama, Takashi
    Takahashi, Kazunori
    Saito, Ryo
    Yamamoto, Atsushi
    Furuya, Shinji
    Akaike, Hidenori
    Hosomura, Naohiro
    Kawaguchi, Yoshihiko
    Amemiya, Hidetake
    Kawaida, Hiromichi
    Inoue, Shingo
    Kono, Hiroshi
    Konishi, Hirotaka
    Otsuji, Eigo
    Ichikawa, Daisuke
    ONCOLOGY REPORTS, 2022, 47 (03)
  • [23] The dawn of precision medicine in diffuse-type gastric cancer
    Ooki, Akira
    Yamaguchi, Kensei
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [24] SERPINE1 Intron Polymorphisms Affecting Gene Expression Are Associated With Diffuse-Type Gastric Cancer Susceptibility
    Ju, Hyoungseok
    Lim, Byungho
    Kim, Minjin
    Noh, Seung-Moo
    Kim, Woo Ho
    Ihm, Chunhwa
    Choi, Bo Youl
    Kim, Yong Sung
    Kang, Changwon
    CANCER, 2010, 116 (18) : 4248 - 4255
  • [25] Differential expression of lipocortin 1 between intestinal-type and diffuse-type gastric cancer
    Sato, M
    Mizoi, T
    Shiiba, K
    Migita, T
    Matsuno, S
    3RD INTERNATIONAL GASTRIC CANCER CONGRESS, 1999, : 395 - 398
  • [26] A Regulatory Polymorphism at Position-309 in PTPRCAP Is Associated with Susceptibility to Diffuse-type Gastric Cancer and Gene Expression
    Ju, Hyoungseok
    Lim, Byungho
    Kim, Minjin
    Kim, Yong Sung
    Kim, Woo Ho
    Ihm, Chunhwa
    Noh, Seung-Moo
    Han, Dong Soo
    Yu, Hang-Jong
    Choi, Bo Youl
    Kang, Changwon
    NEOPLASIA, 2009, 11 (12): : 1340 - 1347
  • [27] EMMPRIN in extracellular vesicles from peritoneal mesothelial cells stimulates the invasion activity of diffuse-type gastric cancer cells
    Sugimoto, Atsushi
    Okuno, Tomohisa
    Miki, Yuichiro
    Tsujio, Gen
    Sera, Tomohiro
    Yamamoto, Yurie
    Kushiyama, Shuhei
    Nishimura, Sadaaki
    Kuroda, Kenji
    Togano, Shingo
    Maruo, Koji
    Kasashima, Hiroaki
    Ohira, Masaichi
    Yashiro, Masakazu
    CANCER LETTERS, 2021, 521 : 169 - 177
  • [28] Differential expression of claudin-4 between intestinal and diffuse-type gastric cancer
    Kuo, Wen-Ling
    Lee, Li-Yu
    Wu, Chi-Ming
    Wang, Chee-Chan
    Yu, Jau-Song
    Liang, Ying
    Lo, Chih-Hong
    Huang, Kuo-Hao
    Hwang, Tsann-Long
    ONCOLOGY REPORTS, 2006, 16 (04) : 729 - 734
  • [29] Clinical Significance of CLDN18.2 Expression in Metastatic Diffuse-Type Gastric Cancer
    Kim, Seo Ree
    Shin, Kabsoo
    Park, Jae Myung
    Lee, Han Hong
    Song, Kyo Yong
    Lee, Sung Hak
    Kim, Bohyun
    Kim, Sang-Yeob
    Seo, Junyoung
    Kim, Jeong-Oh
    Roh, Sang-Young
    Kim, In-Ho
    JOURNAL OF GASTRIC CANCER, 2020, 20 (04) : 408 - 420
  • [30] Prognostic significance of connective tissue growth factor expression in stromal cells in patients with diffuse-type gastric cancer
    Miki, Yuichiro
    Yoshii, Mami
    Miyauchi, Ryoko
    Kasashima, Hiroaki
    Fukuoka, Tatsunari
    Tamura, Tatsuro
    Shibutani, Masatsune
    Toyokawa, Takahiro
    Lee, Shigeru
    Yashiro, Masakazu
    Maeda, Kiyoshi
    ONCOLOGY LETTERS, 2024, 27 (06)
12345